Royal Bank of Canada
ICVX

Royal Bank of Canada’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Royal Bank of Canada’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,509
Closed -$134K – 7845
2023
Q4 		$134K Buy
8,509
+2,433
+40% +$23.4K ﹤0.01% 5425
2023
Q3 		$47K Sell
6,076
-44,582
-88% -$370K ﹤0.01% 5821
2023
Q2 		$504K Buy
50,658
+49,404
+3,940% +$395K ﹤0.01% 3946
2023
Q1 		$7K Sell
1,254
-1,313
-51% -$11.3K ﹤0.01% 6479
2022
Q4 		$21K Buy
2,567
+2,296
+847% +$9.85K ﹤0.01% 6287
2022
Q3 		$1K Buy
271
+146
+117% +$913 ﹤0.01% 7334
2022
Q2 		$1K Sell
125
-1,361
-92% -$10.6K ﹤0.01% 7261
2022
Q1 		$10K Sell
1,486
-1,320
-47% -$20.8K ﹤0.01% 6960
2021
Q4 		$65K Buy
2,806
+1,313
+88% +$33.9K ﹤0.01% 6222
2021
Q3 		$44K Buy
+1,493
New +$50.6K ﹤0.01% 6238

Royal Bank of Canada's ICVX Position: Q1 2024 in Review

Royal Bank of Canada sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 8,509 shares — an estimated $134K sold.

Royal Bank of Canada first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $504K in Q2 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Royal Bank of Canada reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 8,509 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $134K.
  • Royal Bank of Canada first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Royal Bank of Canada's Icosavax, Inc. Common Stock position peaked at $504K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.